Explore every episode of the podcast Medtech Talk
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Episode: 190 - The Evolution of Suki and Bringing Joy Back to Patient Care | 17 Sep 2024 | 00:49:36 | |
In this episode of Medtech Talk, host Geoff Pardo speaks with Punit Soni, CEO of Suki, about using AI to build better technology in healthcare, the origins of Suki, and how Soni shifted from Google to healthcare. Soni also delves into the difficulties and challenges of healthcare, including handling the regulatory aspects and encouraging doctors to adapt to new tech. He also discusses managing failure—as an individual and a company leader—and where we are in the evolution of what Suki is doing. Special thanks to Silicon Valley Bank for sponsoring this episode.
| |||
| Episode: 189 - Liz Kwo on Navigating the Digital Transformation of Healthcare | 23 Jul 2024 | 01:00:12 | |
In this episode of Medtech Talk, host Geoff Pardo speaks with Dr. Liz Kwo, chief commercial officer at Everly Health, about how she got started in the medtech field, her experience at InfiniteMD, and the lessons learned along the way. They also discuss Dr. Kwo’s new book Digital MD: Revolutionizing the Future of Healthcare, which provides an in-depth look at ROI development, how organizations think, sell, and build partnerships, and more. Dr. Kwo also shares her thoughts on the difference between efficacy and effectiveness, customer profiles, the changing role of the consumer (especially when considering data and AI), and what she anticipates in the next 20 years. | |||
| Episode: 180 - From Conception to Commercialization, Jane Chao and Ceribell Are Changing Lives With This Neuromonitoring Breakthrough | 19 Sep 2023 | 00:49:06 | |
Ceribell’s rapid seizure triage product for critical care received FDA’s Breakthrough Designation with an exclusive New Technology Add-on Payment (NTAP) from CMS. Everything about the ClarityPro product—from the innovative EEG headband to the EEG recorder and physician portal has been engineered to enable quick detection and response to non-convulsive seizure in a critical care or ED setting. In this episode of the Medtech Talk podcast, host Geoff Pardo speaks with Jane Chao, CEO of Ceribell, about the path to develop an innovative new product and her personal journey as well. Medtech Talk Links: | |||
| Fractyl’s Rajagopalan Shares Fund-Raising Philosophy | 08 Jan 2018 | 00:36:46 | |
What Went into Fractyl’s $44 million Round? CEO and co-founder Harith Rajagopalan, MD, PhD, discusses his approach to raising new capital and to building the right board. | |||
| We Ask Anders Wold, Head of GE’s Clinical Care Solutions, Where GE Fits in Healthcare’s Future | 15 Dec 2017 | 00:33:57 | |
Anders Wold, president and CEO of GE’s Clinical Care Solutions, is still fascinated by the power new technology can deliver to healthcare. So he’s understandably excited about the opportunities facing this division of GE – and the entire company as well – as we move into healthcare of the future. | |||
| AI Forerunner IDx Explains How New Test Could Cut Healthcare Costs, Improve Diagnosis of Eye Disease | 05 Dec 2017 | 00:23:55 | |
The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this MedtechTalk Podcast, Michael D. Abramoff, MD, PhD, president and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer. | |||
| Norwest’s Mittendorff Details Past Successes and Future Challenges Facing Healthcare Technology | 17 Nov 2017 | 00:38:43 | |
Medtech and Digital Health technology increasingly have more and more in common. In this Medtech Talk Podcast, Robert Mittendorff, MD, a partner at Norwest Venture Partners, explains how Digital Health companies are facing many of the same challenges that vex Medtech start-ups, including the need to obtain approval under new FDA guidelines and to secure reimbursement payments from insurers | |||
| Cardionomic’s Goedeke Talks Team Jackets, Ski Lifts, and Changing How ADHF Is Treated | 10 Nov 2017 | 00:37:52 | |
Steve Goedeke says he was the kid who liked to take things apart. But he’s built a career putting things together including a promising neuromodulation start-up called Cardionomic. In this episode, Goedeke shares the thoughts – and concerns – that went into leaving a seemingly stable gig at Medtronic to lead the new company. He also reveals what ideas he’d consider pursuing before a serendipitous ski trip set him on his current path. | |||
| How Will CEO Pavlidis Help VytronUS Deliver Disruptive Ultrasound Tool to Treat Afib in the EP Lab? | 03 Nov 2017 | 00:34:14 | |
John Pavlidis, president and CEO of VytronUS, has built a strong resume leading and selling Medtech start-ups. Now the self-described engineering “nerd” is leading VytronUS, a start-up combining the powers of imaging, ablation, and robotics to create a powerful new tool that can elevate the precision of treating atrial fibrillation in the electrophysiology lab. | |||
| Alexa! Ask Worrell How Voice Technology, Virtual Reality, and Other Exciting Tech Will Help Medtech | 28 Oct 2017 | 00:37:02 | |
Medtech-device design firm Worrell now is envisioning how Virtual Reality, Augmented Reality, and Voice-enabled Technologies like Amazon’s Alexa might treat chronic disease, manage clinical trials, and restore bonds between patients and physicians. We talk with CEO Kai Worrell and Kristen Shardlow, the company’s director of user experience, about the firm’s work in understanding these exciting technologies. | |||
| Mylea Charvat Says Savonix Working to Turn Cognitive Function into Vital Measure | 20 Oct 2017 | 00:39:59 | |
Faced with an unacceptable diagnosis after her husband was seriously injured in an accident, Savonix CEO Mylea Charvat created a tool to measure cognitive function to aid his recovery. Now Savonix seeks to establish cognitive function as a standard measure of human health. The technology potentially could could fill a huge shortage of physicians while improving patient outcomes and accelerating medical innovation. | |||
| Wahr says Nuvaira gives him a familiar feeling; lays out plans for fund-raising, commercial launch | 13 Oct 2017 | 00:29:34 | |
Nuvaira CEO Dennis Wahr, MD, sees similarities between interventional pulmonology today and interventional cardiology in its early days. He hopes Nuvaira, which is developing a tool to ablate lung tissue, will be able to further the field through upcoming clinical trials and fund-raising. | |||
| CEO Jeffrey Brewer Details How His Family’s Health Helped Him Find Medtech’s Bigfoot in Diabetes | 06 Oct 2017 | 00:33:42 | |
An ailing wife and son forced Bryan Mazlish to hack a cell phone, glucose monitor, and insulin pump to create an artificial pancreas. In this MedtechTalk Podcast, Jeffrey Brewer, CEO and president of Bigfoot Biomedical, explains how he and Mazlish came to form the privately held start-up. Brewer explains how his son’s diagnosis – and at least one near-fatal experience – pushes him forward to ensure Bigfoot leads the class of next-generation devices that may someday come close to creating a cure for this dreaded disease.Learn More about Medtech Talk: https://goo.gl/o6Ue5u | |||
| Episode: 179 - Overcoming Valuation Overhang – Implications on Raising Capital and Exits | 18 Jul 2023 | 00:51:38 | |
How has the bullishness of 2016-2022 impacted public markets and private companies? In this special episode of Medtech Talk, we share Geoff Pardo’s Medtech MVP 2023 panel, featuring Tak G Cheung, Partner at New Enterprise Associates; J.P. Peltier, Managing Director of Global Head, Healthcare Investment Banking at Piper Sandler; Michael Ryan, VP of Venture Capital & Business Development at Boston Scientific Corp; Gwen Watanabe, Managing Director at H.I.G. Capital; and Rob Winklemann, Managing Partner & CEO at Credo 180. The panelists discuss the implications for private companies, particularly those that were financed during the boom times, as well as strategies for keeping private companies financed, and the outlook for liquidity via M&A or IPO. | |||
| CEO Rogers Shares the Experiences that Helped Her Set a Successful Course for High Flying Silk Road | 29 Sep 2017 | 00:42:04 | |
Silk Road Medical CEO Erica Rogers gives an honest look back at how her past successes and failures have helped her set the course for one of Medtech’s most promising stories. Flush with capital, Silk Road is disrupting carotid artery treatment. | |||
| IntuiTap Medical CEO Traver Says “Stud Finder for the Spine” Could Save Time While Avoiding Frustration and Pain | 22 Sep 2017 | 00:33:36 | |
Jessica Traver, CEO of IntuiTap Medical, says the Texas-based start-up could solve serious but often overlooked complications of spinal punctures. The company combines imaging, analytics, and technology to help physicians place needles more safely. | |||
| What Is AirXpanders CEO Dodson’s Biggest Concern? Can the Company Make Enough Product to Meet Demand | 15 Sep 2017 | 00:33:06 | |
Scott Dodson, president and CEO of AirXpanders, explains how the company used OUS experience and financing to get its AeroForm Tissue expander system through rigorous FDA review. The firm now is positioned to benefit from patient demand and a healthy reimbursement system. | |||
| Personal Tragedy Puts AUM Founder and CEO Marie Johnson on Journey to Create a Device, Save Lives | 08 Sep 2017 | 00:48:19 | |
Marie Johnson, CEO and founder of AUM Cardiovascular, lost her husband, Rob, to a heart attack. The tragedy led her to develop CADence, a handheld device that she believes will save lives by identifying telltale signs of cardiovascular disease. | |||
| Entrepreneur Extraordinaire Wallace Shares Where He’s Finding New Ideas and Fresh Capital | 24 Aug 2017 | 00:11:39 | |
George Wallace says his Intersect incubator created 13 companies over 20 years, and exited eight of them. That’s a pretty good batting average. But innovators like Wallace continue to innovate, not only with technology but also with finding new ways to create meaningful Medtech companies. | |||
| Keynote Conversation: CEO José Almeida Rebuilds Baxter International for the Future | 17 Aug 2017 | 00:37:46 | |
Baxter CEO Joe Almeida discusses the challenges of taking over the hospital-products maker, reshaping its culture, focusing its strategy for the future, and investing in its people. | |||
| CEO Barad Explains How Osso VR Uses Virtual Reality to Solve a Problem No One Knew Existed | 08 Aug 2017 | 00:42:03 | |
Justin Barad talks about taking VR out of the gaming space with innovative software that will transform how orthopedic surgeons train in the OR. | |||
| Endeavour Vision’s Ellias Reveals the Path from Pre-Med to Medtronic to Investing in Medtech | 04 Aug 2017 | 00:46:59 | |
Ask Endeavour Vision’s Katie Ellias what song best represents her career path to venture capital and she’d probably say, “The Long and Winding Road.” Hear how the VC established a career path that took her from Pre-Med plans to Medtronic and then Venture Capital. | |||
| Hear a Surprising Reason Jonathan Norris is Bullish on Medtech Investments in 2017 and Beyond | 28 Jul 2017 | 00:24:06 | |
Jonathan Norris of Silicon Valley Bank follows up his recent Medtech Conference presentation with insights on healthcare exits, the latest M&A chatter, the resurgence of biopharma deals, which type of Medtech start-up gets the most action, and the drastic decline in Series A device deals. | |||
| SightLine’s Biller Advises Entrepreneurs and Investors to Look at Strength of a Syndicate | 21 Jul 2017 | 00:13:56 | |
SightLine general partner Joe Biller shares his insights on the venture market, including advice for companies looking for – and working with – venture capital investors. | |||
| Episode: 178 - Doug Godshall’s Business Growth Through Sales Strategies and Leadership | 21 Jun 2023 | 01:02:13 | |
Doug Godshall, President and CEO of Shockwave Medical, started off selling T-shirts as an engineering student. Today, he leads the most successful high-growth medtech company in the last twenty years. In this episode of Medtech Talk, host Geoff Pardo speaks with Godshall, who discusses his start in medical devices, experiences in a major medtech company, leadership and culture, and what it takes to succeed in the field. Godshall details the strategies behind sales such as understanding your customer’s full needs and why the quality and usefulness of your product is more important than the amount you sell. He also shares his perspective on the type of company culture that creates a comfortable and collaborative environment that paves the way to success. Medtech Talk Links: | |||
| Mahoney Shares What Surprised Him at Boston Scientific and How the Company Turned Around its Culture | 13 Jul 2017 | 00:41:17 | |
What steps did Boston Scientific – under Mahoney’s leadership – take to unlock such significant growth? In an interview at the Medtech Conference, Mahoney – interviewed by Kevin Hykes, CEO of Metavention - laid out some of the meaningful changes Boston Scientific made. | |||
| Berman Give Honest Opinions on His Golf Game and the Opportunities for Future Medtech Innovators | 07 Jul 2017 | 00:09:19 | |
Serial entrepreneur Mike Berman shares how he’s seen the Medtech innovation sector evolve over the years. Times are tougher, but Berman sees reason for hope as well as concern. | |||
| Klein Shares how NEA Plans to Put More Than $300 Million to Work in Medtech Companies | 26 Jun 2017 | 00:12:29 | |
This week, New Enterprise Associates – known to its friends as NEA – announced closing on a $3.3 billion venture capital fund, with roughly 10% of that total going to Medtech companies. We asked partner Justin Klein, MD, how might the $300 million or so invest in Medtech companies be deployed differently than in the prior fund. | |||
| ReCor’s Weiss Sees Medtech’s Rebound, Talks Renal Denervation and Innovative Strategic Financing | 15 Jun 2017 | 00:24:40 | |
Andrew Weiss, president & CEO of ReCor Medical, says Medtech is alive and kicking. This is an exceedingly positive statement from the CEO of a renal denervation company, an area that has been particularly hit hard. Hear his take on Medtech’s future and how Recor is making it work. | |||
| Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups | 08 Jun 2017 | 00:18:33 | |
Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups. | |||
| Baxter Chairman & CEO Joe Almeida Explains How to Bring Innovation to a Big Company’s Culture | 03 Jun 2017 | 00:18:06 | |
Joe Almeida, CEO, President, and Chairman of Baxter International, Inc. joined Baxter at the beginning of 2016. He knew immediately the company needed an infusion of innovative spirit to begin to move forward. | |||
| Medtech Conference Co-Chair Kevin Hykes Hits the Highpoints; Catch Us on Facebook Live | 26 May 2017 | 00:16:28 | |
Medtech Conference Co-Chair Kevin Hykes, who is finishing up his two-year tour of duty as a conference co-commander, reviews the agenda for next week’s Conference. | |||
| Outset CEO Trigg Talks Dialysis, Fundraising, and What Makes a Medtech Career Matter | 19 May 2017 | 00:46:36 | |
Outset CEO Leslie Trigg updates Medtech Talk listeners on her company’s bid to bring disruption to dialysis. She also shares some sage advice about what matters most in a career. | |||
| A Little Bit Medtech, A Little Bit Tech: Murj CEO Butka Explains How Murj Combines Best of Both | 12 May 2017 | 00:37:54 | |
Todd Butka, the CEO and founder of Murj, personifies the much ballyhooed crossover between Medtech and Tech. The start-up is developing a software application that enables providers to efficiently manage data from implantable cardiac devices. | |||
| Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google | 03 May 2017 | 00:25:57 | |
Paul Yock, MD, started Stanford’s Byers Center for Biodesign to help teach innovation. While the idea didn’t excite everyone, the center has emerged as the hub of entrepreneurial excellence. Dr. Yock speaks to the role of innovation and how it impacts Medtech. | |||
| Episode: 177 - Launching a New Category of Orthopedics: Moximed’s Journey and Trial Results | 24 May 2023 | 00:57:20 | |
In his early education Anton Clifford was advised against focusing on both science and economics. But he’s put that education to good use in his entrepreneurial career. With a foundation in engineering, Clifford quickly turned to medical devices. First in his native Ireland and later in the US with Abbott Laboratories, Clifford got firsthand experience with device engineering as well as the challenges of launching new products, divisions, and companies. On the journey to his current endeavor, Clifford had narrowed his focus to finding an engineering problem with a mechanical component: a massive unmet need with a surgical solution that was under-adopted. As he considered market opportunities, a friend and mentor, Josh Makower, directed him: You’re not trying to make something work; you’re trying to kill ideas. The last idea standing, so to speak, was an implantable shock absorber, reducing load to the knee joint. After years of development, Moximed has released its FDA study on the most recent product—Misha—with “phenomenal outcomes.” Compared to a surgical alternative, Misha showed superior recovery, pain, function, and no mechanical failures. | |||
| CEO Randall Recalls the Tale of Trans1 and Explains Why Omnilife Will Make Its Mark in Orthopedics | 28 Apr 2017 | 00:39:18 | |
Rick Randall’s initial foray into leading a Medtech company represented a bit of a fairy tale. But his next chapter – starting and leading spine company Trans1 – serves as a bit of a Medtech nightmare. | |||
| Randall Recaps Journey from Teaching in High School Classroom to Leading Medtechs as a CEO | 20 Apr 2017 | 00:41:04 | |
Rick Randall landed his first job in Medtech on a bet. Today, he’s one of the sector’s most experienced CEOs. In the first part of a two-part interview with Medtech Talk, Randall, the CEO of OMNIlife science, the robotic-assisted surgery company, explains how serendipity has helped guide his path into the sector. | |||
| Stanford’s Blumenkranz Delivers His State of Innovation Address. Spoiler: It Includes Lasers | 13 Apr 2017 | 00:27:57 | |
Serial innovator Mark Blumenkranz, MD, who last year moved into an emeritus position at Stanford, shares his enthusiasm and concerns for the future of innovation in the US. | |||
| Advice of the Valkyrie – GE Venture’s Lisa Suennen Explains How Medtechers Can Find Their Voice | 06 Apr 2017 | 00:39:14 | |
For more than a decade, Lisa Suennen, Senior Managing Director, healthcare at GE Ventures and Managing Partner at Venture Valkyrie, LLC, has blogged and opined on the healthcare industry. In this podcast she reveals what first led her to speak up and shares how Medtech execs can find their own voices. She also talks about CSweetner.org, a not-for-profit she created to help women executives rise to the C-suite. | |||
| Former VC Nim Shah Dishes on JP Morgan, the Four Horsemen, and What It’s Like Joining a Start-Up | 30 Mar 2017 | 00:47:12 | |
Nim Shah left Domain Associates to take on the chief business officer role at hot Start-Up Fractyl Laboratories. Hear why he made the change, what he feels went wrong for Medtech, and what’s next for Fractyl. | |||
| Egeland’s Experience, Curiosity, and Roots Lead Him to Building Out a B&D Career at Medtronic | 24 Mar 2017 | 00:33:21 | |
Ryan Egeland, senior director, business development & licensing at Medtronic, is searching for tech and start-ups that bolster the Medtech giant’s surgical innovations group. | |||
| Managing Director Kirk Nielsen Talks Origins, Medtech, and Versant Ventures’ new $400 Million Fund | 17 Mar 2017 | 00:29:21 | |
Kirk Nielsen’s path to Versant passed through thoughts of medical school, a short stint in the NHL, and a span at Medtronic. Today, Nielsen represents the global VC’s interests in Medtech, serving as part of a new generation of partners taking over from the VC giant’s founders. | |||
| Trod Medical Focused on Developing RF Ablative Tools to Perform Precise Surgery on Soft Tissue | 10 Mar 2017 | 00:21:23 | |
Trod Founder and CEO Andre Faure tells the tale of Trod, a low-capital-burning start-up focused on introducing a next-generation of ablation tools to treat the prostate and other soft tissue. | |||
| Amphora's Tom Ressemann Looks Back On A Start-Up Life, Answers The Question: What Makes a Good CEO | 03 Mar 2017 | 00:39:01 | |
You can’t be involved in as many successful start-ups as Tom Ressemann and not walk away with great lessons and valuable experiences. The former Entellus founder and CEO examines the wins and challenges and explains how they’re guiding his hand at Amphora Medical. | |||
| FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups | 24 Feb 2017 | 00:34:03 | |
Zeshan Muhammedi thinks he and his co-founders of FundRx have identified some “misalignments” in funding Medtechs. The solution may be FundRx, a new breed of venture capital firm bringing LPs, KOLs, and entrepreneurs on the same page. | |||
| Episode: 176 - Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes | 26 Apr 2023 | 00:56:46 | |
With a background as a trauma nurse and experience running clinical research programs, Stacey Pugh brought quite a bit of patient-focused experience with her when she shifted to industry. After several roles in the neurovascular space, now she’s leading the charge at Endogenix, which is using pulsed electric fields to treat Type 2 Diabetes. She and host, Geoff Pardo, talk about a medical officer’s first experience doing sales, the challenges in affecting change management in primary care, funding businesses with SPACs, and more. | |||
| SetPoint CEO Arnold Recalls Path to Medtech, Progress in Using Neuromod to Alleviate Inflammation | 17 Feb 2017 | 00:31:19 | |
Long ago, Tony Arnold wondered how he might find an opening in Medtech. Today, he’s leading one of the sector’s most novel start-ups, SetPoint Medical, which is using the nervous system to ease inflammation. | |||
| FDA Building Effective Fast Track for US Medtechs While Other Countries Starting to Show Delays | 14 Feb 2017 | 00:15:30 | |
Lisa Wipperman Heine, COO of Mitralign, says the FDA is making quicker work of review times. But the same might not be said for other countries where Medtechs once had a faster time to market. In this interview at the offices of Fox Rothschild in Minneapolis, the Medtech veteran lays out Mitralign’s success with the agency’s Early Feasibility program. | |||
| Optum’s Clark Says Medtechs Need to Craft Effective Message to Win Support from Payers and Providers | 05 Feb 2017 | 00:17:06 | |
Steve Clark, senior vice president at Optum Life Sciences, says healthcare rests in the “nascent” stages of questioning effectiveness of medical tech. Successful start-ups will find the right answers to those questions. | |||